Technical Analysis for ATRS - Antares Pharma, Inc.

Grade Last Price % Change Price Change
grade B 3.55 -1.93% -0.07
ATRS closed down 1.93 percent on Friday, September 20, 2019, on 1.51 times normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical ATRS trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Spinning Top Other 0.00%
Upper Bollinger Band Walk Strength 0.00%
Overbought Stochastic Strength 0.00%
Bearish Engulfing Bearish -1.93%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.93%
Upper Bollinger Band Walk Strength -1.93%
Stochastic Sell Signal Bearish -2.47%
Narrow Range Bar Range Contraction -2.47%
NR7 Range Contraction -2.47%

Older signals for ATRS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies, and topical gel-based medicines worldwide. The company's products include Tjet/Zomajet, the needle-free auto injectors to deliver human growth hormone treatment to children without the use of a needle; twin-jector EZ II needle free injectors; Medi-Jet auto injectors; Elestrin, an estrogen replacement gel for the treatment of hot flashes; and Gelnique 3%, an oxybutynin gel product for the treatment of overactive bladder. The company is also developing OTREXUP, a product for the delivery of methotrexate using Medi-Jet technology for the treatment of rheumatoid arthritis, poly-articular-course juvenile rheumatoid arthritis, and psoriasis; and VIBEX QS T, an auto injector for the treatment of testosterone deficiency or replacement therapy. In addition, it is developing Vibex auto injectors; disposable pen injectors; and Nestragel, a contraceptive gel. Antares Pharma, Inc. has collaborative and license agreements with Ferring Pharmaceuticals BV; Teva Pharmaceutical Industries, Ltd.; JCR Pharmaceuticals Co., Ltd.; Actavis, Inc.; Daewoong Pharmaceuticals; BioSante Pharmaceuticals, Inc.; Meda Pharmaceuticals; Population Council; and Pfizer Inc. The company was founded in 1979 and is headquartered in Ewing, New Jersey.
Biotechnology Health Pharmaceutical Pharmacology Rheumatoid Arthritis Psoriasis Medical Equipment Overactive Bladder Testosterone Deficiency Teva Pharmaceutical Industries
Is ATRS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.96
52 Week Low 2.53
Average Volume 911,165
200-Day Moving Average 3.113
50-Day Moving Average 3.2574
20-Day Moving Average 3.3825
10-Day Moving Average 3.501
Average True Range 0.1376
ADX 24.74
+DI 30.0411
-DI 14.3837
Chandelier Exit (Long, 3 ATRs ) 3.3772
Chandelier Exit (Short, 3 ATRs ) 3.4728
Upper Bollinger Band 3.714
Lower Bollinger Band 3.051
Percent B (%b) 0.75
BandWidth 19.600887
MACD Line 0.1031
MACD Signal Line 0.075
MACD Histogram 0.0281
Fundamentals Value
Market Cap 555.24 Million
Num Shares 156 Million
EPS -0.12
Price-to-Earnings (P/E) Ratio -29.58
Price-to-Sales 5.48
Price-to-Book 7.21
PEG Ratio -0.24
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.81
Resistance 3 (R3) 3.81 3.74 3.76
Resistance 2 (R2) 3.74 3.67 3.73 3.75
Resistance 1 (R1) 3.64 3.63 3.61 3.64 3.73
Pivot Point 3.57 3.57 3.55 3.56 3.57
Support 1 (S1) 3.47 3.50 3.44 3.47 3.37
Support 2 (S2) 3.40 3.46 3.39 3.35
Support 3 (S3) 3.30 3.40 3.34
Support 4 (S4) 3.30